Introduction
Melanoma is an aggressive form of cancer that originates in pigment-producing cells known as melanocytes. While most people associate melanoma with the skin exposed to sunlight, it can also develop in mucosal areas of the body where sunlight is not a factor. One of the rarest and most challenging forms is vulvar melanoma, a type of cancer that develops on the external female genitalia. Although uncommon, this form of melanoma is particularly dangerous due to its tendency to be diagnosed at a later stage. Many women may overlook early symptoms or confuse them with benign vulvar conditions, which delays medical attention.
Understanding this disease—its symptoms, risk factors, diagnostic steps, and treatment options—is essential for early detection and improved outcomes. Because vulvar melanoma does not behave like more common skin melanomas, awareness among both clinicians and women is crucial.
Table of Contents
What Is Vulvar Melanoma?
Vulvar melanoma arises from melanocytes located within the vulva, including the labia majora, labia minora, clitoris, and perineal regions. These melanocytes produce melanin, the pigment responsible for skin color. Unlike melanoma that appears on sun-exposed skin, vulvar melanoma is classified as a mucosal melanoma, which behaves differently, spreads more aggressively, and often presents diagnostic challenges.
It is important to distinguish vulvar melanoma from other types of cancers that affect the vulva. The majority of vulvar cancers—about 70%—are squamous cell carcinomas, which originate from the squamous cells covering the vulvar skin. Vulvar melanoma, in contrast, represents a much smaller percentage of cancers in this region but carries a more serious prognosis.
Vulvar melanoma also differs from cutaneous melanoma in its underlying causes, progression pattern, and response to treatment. Because the vulva is not frequently examined and changes may not be easily seen, many women do not notice abnormalities until the tumor has grown significantly.
Prevalence and Demographics
Although melanoma is a common cancer overall, vulvar melanoma is extremely rare. It accounts for less than 10% of all vulvar cancers and only about 1% of all melanomas in women. Despite its rarity, the disease is clinically significant because of its aggressive nature and low survival rates compared to cutaneous melanomas.
Vulvar melanoma is most frequently diagnosed in postmenopausal women, with a median age of around 68 years at diagnosis. However, it can occur at any age and should not be dismissed in younger patients. While more common among white women, this cancer can affect women of all ethnic backgrounds.
Because there is no routine screening test for vulvar melanoma, awareness and self-examination are particularly important in older women who may already be experiencing vulvar atrophy or other age-related changes that mask symptoms.
Causes and Risk Factors
The exact cause of vulvar melanoma remains unclear. Unlike cutaneous melanoma, which is strongly associated with ultraviolet radiation from the sun, mucosal melanomas—including vulvar melanoma—do not share this environmental risk factor.
Researchers and clinicians have identified several potential risk factors that may contribute to the development of vulvar melanoma:
Age and Menopausal Status
Risk increases significantly with age, especially after menopause. Hormonal changes may play a role, although the exact mechanisms are not fully understood.
Personal or Family History of Melanoma
Women with a history of melanoma elsewhere on the body, or with a close family member affected by melanoma, may have a higher risk.
Atypical Moles (Dysplastic Nevi)
Although less common in mucosal areas, atypical moles may indicate a predisposition to melanoma.
Genetic Factors
Studies show potential associations with mutations in genes such as KIT, NRAS, and BRAF, although their impact differs from cutaneous melanoma. Research is ongoing to better understand these molecular pathways.
Despite these identified factors, many women diagnosed with vulvar melanoma have no known risk factors, making awareness of symptoms even more critical.
Symptoms
One of the biggest challenges with vulvar melanoma is that early symptoms are often subtle. Many women attribute discomfort or discoloration to benign conditions such as yeast infections, dermatitis, or normal aging changes. This delay can allow the tumor to progress.
Common symptoms of vulvar melanoma include:
Itching (Pruritus)
Persistent or unexplained itching is one of the most frequently reported early signs.
Bleeding
Any bleeding not related to menstruation or trauma should be evaluated.
Discoloration
Lesions may appear black, brown, blue, red, pink, or even white. Because vulvar melanoma can be amelanotic (non-pigmented), unusual pink or red nodules should not be ignored.
Pain or Tenderness
Pain may appear in later stages but can sometimes occur early.
Lumps or Nodules
A new growth, swelling, or raised area may indicate tumor development.
Ulceration or Open Sores
Non-healing ulcers are a concerning sign and require immediate evaluation.
Monitoring Lesions Using the ABCDE Rule
Although developed for skin melanoma, the ABCDE rule can help identify suspicious vulvar lesions:
- A – Asymmetry: One half looks different from the other.
- B – Border: Irregular, ragged, or blurred edges.
- C – Color: Multiple colors or uneven pigmentation.
- D – Diameter: Larger than 6 mm (though smaller lesions may also be melanoma).
- E – Evolving: Any change in size, shape, color, or symptoms.
Women should seek medical evaluation for any persistent change lasting more than two weeks.
Diagnosis
Vulvar melanoma cannot be detected through a Pap smear, which only screens for cervical abnormalities. Therefore, diagnosis relies on clinical assessment and targeted evaluation of suspicious lesions.
Physical Examination
A gynecologist or dermatologist examines the vulva carefully for pigmentation changes, ulcers, nodules, or irregular lesions.
Biopsy (Gold Standard)
A biopsy is essential for confirming a diagnosis of vulvar melanoma. This may involve incisional, excisional, or punch biopsy depending on the lesion’s size and location.
Pathology and Breslow Thickness
The pathologist evaluates:
- Tumor type
- Depth of invasion (Breslow thickness)
- Presence of ulceration
- Mitotic rate
The Breslow thickness measurement is one of the most important prognostic factors. Thicker tumors have a higher risk of metastasis.
Imaging for Staging
To determine the extent of the disease, clinicians may use:
- CT (Computed Tomography)
- MRI (Magnetic Resonance Imaging)
- PET (Positron Emission Tomography)
These tests help identify lymph node involvement or distant metastasis, which guide therapeutic decisions.
Stages and Prognosis
Staging vulvar melanoma follows general melanoma staging principles, focusing on:
- Tumor depth and size
- Lymph node involvement
- Distant metastasis
Prognostic Value of Breslow Thickness
Thin tumors (<1 mm) have a much better prognosis than those with deeper invasion.
Survival Rates
Although survival depends on many individual factors, data show:
- Overall 5-year survival: ~47%
- No lymph node involvement: ~65%
- With lymph node involvement: ~27%
Recurrence is unfortunately common, even after aggressive treatment, emphasizing the need for lifelong monitoring.
Treatment Options
Treatment is tailored based on the stage of the cancer, overall health, and tumor characteristics. Vulvar melanoma requires management by a multidisciplinary team, including gynecologic oncologists, dermatologists, surgeons, and medical oncologists.
Surgical Treatment (Main Approach for Localized Disease)
Wide Local Excision
The preferred initial treatment involves removing the tumor with a margin of healthy tissue to reduce recurrence risk.
Partial or Radical Vulvectomy
In more advanced cases, removal of larger portions of the vulva may be necessary.
Sentinel Lymph Node Biopsy
Determines whether cancer has spread beyond the primary lesion. If positive, further lymph node dissection may be needed.
Other Therapies
Immunotherapy
Medications such as checkpoint inhibitors (e.g., pembrolizumab, nivolumab) have improved outcomes in advanced melanoma and may also benefit patients with vulvar melanoma.
Targeted Therapy
For tumors with specific genetic mutations, targeted therapies may offer additional treatment options.
Chemotherapy
Less effective than immunotherapy or targeted therapies but sometimes used in advanced cases.
Radiation Therapy
Used selectively—for example, when surgery is not possible or to treat lymph node involvement.
Treatment decisions depend on tumor size, spread, patient age, and overall health condition.
Living With and After Treatment
Regular Follow-Up
Because recurrence is common, follow-up is essential:
- Every 3–4 months during the first two years
- Every 6 months in years 3–5
- Annually thereafter
Follow-up may include physical exams, imaging, and evaluation of new or recurring symptoms.
Psychological and Emotional Support
Receiving a diagnosis of vulvar melanoma can be overwhelming. Many women experience anxiety, fear of recurrence, and changes in body image.
Support strategies include:
- Psychological counseling
- Support groups for rare cancers
- Pelvic floor therapy after surgery
- Sexual health counseling
Addressing these aspects is crucial for quality of life.
FAQ About Vulvar Melanoma
1. What does vulvar melanoma look like?
Vulvar melanoma can appear in many forms, which makes it difficult to identify without a medical exam. It may present as:
A darkly pigmented spot or patch (black, brown, blue)
A pink, red, or white lesion (amelanotic melanoma)
A raised lump or nodule
An ulcerated or bleeding area
An irregularly shaped mole with uneven borders or multiple colors
Some lesions look flat, while others appear raised. Because the vulva is not an area people commonly examine, even small changes should be taken seriously. Any new or evolving spot, discoloration, or bump deserves immediate medical evaluation.
2. What are the symptoms of vulvar melanoma?
mptoms are often subtle at first, which contributes to late diagnosis. Common signs include:
Persistent itching or irritation
Bleeding from the vulva
Pain, tenderness, or burning sensations
A mole or lesion that changes color, size, or shape
A new lump or nodule
Discoloration ranging from black, brown, red, pink, blue, to white
Non-healing sores or ulcerations
Many women mistake these symptoms for infections or benign skin conditions. Any unexplained vulvar change lasting more than two weeks should be
3. How is vulvar melanoma treated?
Treatment depends on the stage, tumor depth, and whether lymph nodes or distant organs are affected. Management usually includes:
Surgery (main treatment for localized disease):
Wide local excision to remove the tumor with safety margins
Partial or radical vulvectomy in advanced cases
Sentinel lymph node biopsy to check for spread
Systemic treatments for advanced or recurrent disease:
Immunotherapy: Checkpoint inhibitors (like pembrolizumab or nivolumab)
Targeted therapy: Used when tumors carry specific mutations
Chemotherapy: Less effective but used in select situations
Radiation therapy: Sometimes used for lymph nodes or unresectable tumors
Care is typically coordinated by a multidisciplinary oncology team.
4. Is vulvar melanoma deadly?
Vulvar melanoma is considered an aggressive and potentially deadly cancer, especially when diagnosed late. Factors that influence survival include:
Tumor depth (Breslow thickness)
Whether lymph nodes are involved
Presence of metastasis
Overall, the 5-year survival rate is about 47%, but this rises to ~65% when there is no lymph node involvement. If lymph nodes are affected, survival drops to around 27%.
Early detection dramatically improves outcomes, which is why any suspicious vulvar lesion or symptom should be evaluated pro
Conclusion
Vulvar melanoma is a rare but aggressive cancer that requires increased awareness among women and healthcare providers. Early detection dramatically improves outcomes, yet diagnosis frequently occurs at advanced stages due to subtle symptoms and lack of routine screening. Any new lesion, discoloration, lump, or persistent vulvar discomfort should prompt a medical evaluation. With timely diagnosis, appropriate treatment, and consistent follow-up, women can significantly improve their prognosis and maintain a better quality of life.
Written by a Gynecologist based on medical experience and scientific evidence to help you make informed decisions about Vulvar Melanoma
